Related Experiment Video
Updated: Aug 9, 2025

A New Toolkit for Evaluating Gene Functions using Conditional Cas9 Stabilization
Published on: September 2, 2021
Reining in Cas13a activity with N-terminal removable tags expands Cas13a based molecular sensing and enables precise
Wenjun Liu1, Xuena Zhu2, Ling Li3
1Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310003, China; Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310003, China; The Innovation Center for the Study of Pancreatic Diseases of Zhejiang Province, Zhejiang University Cancer Center, Hangzhou, 310003, China.
Abstract:
Activation of Cas13 is exclusively dependent on crRNA-target RNA hybridization according to the canonical mode of Cas13 action. Upon activation Cas13 can cleave both target RNA and any surrounding RNA. The latter has been well adopted by therapeutic gene interference and biosensor development. This work for the first time, rationale designs and validates a multi-component controlled activation system of Cas13 by N-terminus tagging. A composite SUMO tag comprised of His, Twinstrep, and Smt3 tags fully suppresses target dependent activation of Cas13a by interfering with crRNA docking. The suppression releases upon proteases mediated proteolytic cleavage. The modular composition of the composite tag can be altered to fulfill customized response to alternative proteases. The biosensor SUMO-Cas13a is able to resolve a broad concentration range of protease Ulp1 with a calculated LOD of 48.8pg/μL in aqueous buffer. Further, in accordance with this finding Cas13a was successfully programmed to exert target gene knock down preferentially in SUMO protease high cell types. In summary the discovered regulatory component not only fulfills Cas13a based protease detection for the first time, but also delivers a novel strategy for multi-component controlled activation of Cas13a toward temporal and spacial precision.
Insights
Researchers developed a novel controlled activation system for Cas13a using N-terminus tagging. This system enables precise gene knockdown and protease detection by regulating Cas13a activity with SUMO tags and proteases.
Area of Science:
- Molecular Biology
- Biotechnology
- Gene Editing Tools
Background:
- Cas13 enzymes are RNA-guided RNases activated by target binding, leading to collateral cleavage of non-target RNAs.
- This collateral activity is utilized in gene interference and biosensing applications.
- Controlling Cas13 activation remains a challenge for precise temporal and spatial applications.
Purpose of the Study:
- To design and validate a novel multi-component system for controlled activation of Cas13a.
- To develop a Cas13a-based biosensor for protease detection.
- To enable targeted gene knockdown in specific cell types based on protease levels.
Main Methods:
- Engineered a composite SUMO tag (His, Twinstrep, Smt3) fused to the N-terminus of Cas13a to suppress its activity.
- Investigated protease-mediated cleavage of the SUMO tag to release Cas13a activity.
- Developed a biosensor utilizing SUMO-Cas13a to detect the protease Ulp1.
- Programmed SUMO-Cas13a for targeted gene knockdown in cells with high SUMO protease expression.
Main Results:
- The composite SUMO tag effectively suppressed target-dependent activation of Cas13a by interfering with crRNA binding.
- Protease-mediated cleavage of the tag restored Cas13a activity, allowing for controlled activation.
- The SUMO-Cas13a biosensor demonstrated a limit of detection (LOD) of 48.8 pg/μL for Ulp1.
- Achieved preferential target gene knockdown in cells expressing high levels of SUMO protease.
Conclusions:
- A novel regulatory system for Cas13a activation based on N-terminus SUMO tagging was successfully developed.
- This system enables Cas13a-based protease detection for the first time.
- The strategy provides a new method for achieving temporal and spatial control over Cas13a activity for therapeutic and diagnostic applications.
Related Concept Videos
Experimental RNAi
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

